This review assessed the efficacy, effectiveness and toxicity of metoclopramide for the treatment of gastroesophageal reflux disease (gerd) in infants given the small number of studies found, the lack of similarity between the included studies in terms of population, metoclopramide doses and outcomes, and the small sample sizes and lack of consistency in the literature, the authors. Metoclopramide for the treatment of gastroesophageal reflux disease in infants a systematic review. Abstract metoclopramide is a commonly used drug to treat gastroesophageal reflux disease in infants given its widespread use and growing concern about toxicity in this population, we conducted a systematic review of metoclopramide for the treatment of gastroesophageal reflux disease in infants.
metoclopramide for the treatment of gastroesophageal reflux disease in infants a systematic review
Reflux disease in infants given its widespread use and growing concern about toxicity in this population, we conducted a systematic review of metoclopramide for the treatment of gastroesophageal reflux disease in infants methodswe performed a systematic search of pubmed and bibliographies of rele-vant review articles. Objective. the goal of this systematic review by the american pediatric surgical association outcomes and evidence-based practice committee was to derive recommendations from the medical literature regarding the surgical treatment of pediatric gastroesophageal reflux disease (gerd).. Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review. pediatrics 2006; 118:746. maclennan s, augood c, cash-gibson l, et al. cisapride treatment for gastro-oesophageal reflux in children..
